Reports from the Moskal group using GBM cell lines in differentiation-promoting conditions suggested that ST6GAL1 levels were low in GBM and that loss of ST6GAL1 would be protumorigenic (27, 28). The gene discussed is ST6GAL1; the disease is glioblastoma.